In critical COVID-19 patients, a rise in serum IL10 levels occurs subsequently to elevated levels of innate inflammatory molecules IL-1β, IL-6, IL-8, and sTNFR1 during the course of the infection [47]. This evidence concerns the gene IL1B and COVID-19.